Microneedles (MNs) hold significant potential for applications in transdermal drug delivery and biosensing. However, when traditional 3D printing technology is used for their manufacture, a substantial deviation in output size occurs. The effects of various parameters on the morphology of MNs produced through microscale 3D printing remain unclear. This study investigated the relationship between the design and fabrication of acrylic resin MNs and their output forms via a projection microstereolithography (PµSL) technology system. Modifying the shape parameters and array configurations elucidates the causes of size deviation and proposes a control strategy. This is particularly significant for the prototyping and mold manufacturing of MNs in relevant fields. This study indicates that a printing layer thickness of 10 µm optimally balances efficiency and clinical conversion requirements. Additionally, an exposure intensity of 65 mW/cm2 achieves both a high fidelity and an appropriate base size. The printing angle significantly influences the morphology and mechanical properties of MNs. The diameter and aspect ratio of solid MNs correlate with their dimensional stability. Clinically, conical or quadrilateral MNs with defined parameters are recommended. A critical spacing (≥40 µm) and an optimal arrangement of the MN arrays were established. The specific exposure intensity and vertical printing angle of the hollow MNs ensure the precision of the micropore diameter and wall thickness. This approach offers theoretical insights and process parameters essential for high-precision, customizable MN engineering design.
Recent studies have identified microneedle (MN) arrays as promising alternatives for transdermal drug delivery. This study investigated the properties of novel staggered MN arrays design featuring two distinct heights of MNs. The staggered MN arrays were precisely fabricated via PμSL light-cured 3D printing technology. The arrays were systematically evaluated for their morphology, fracture force, skin penetration ability, penetration mechanism, and drug delivery capability. The results demonstrated that the staggered MN arrays punctured the skin incrementally, leveraging the benefits of skin deformation during the puncture process. This approach effectively reduced the puncture force needed, achieving a maximum reduction of approximately 80.27% due to variations in the staggered height. Additionally, the staggered design facilitated skin penetration, as confirmed by the results of the rat skin hematoxylin-eosin (H&E) staining experiments. Compared with 3D-printed planar structures and highly uniform MN arrays, the staggered design exhibited enhanced hydrophilicity, as evidenced by a reduction in the contact angle from approximately 93° to 70°. Simulated drug release images of both coated and hollow staggered MNs illustrated the release and delivery capabilities of these structures across various skin layers, and the staggered design expanded the effective area of the MN arrays within the vertical dimension of the skin layers. This study offers both experimental and theoretical foundations for developing MN arrays with three–dimensional structural distributions, thereby facilitating advancements in MN array technology.